Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 20, Issue 9

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Investigational Drugs, Volume 20, Issue 9 (2011)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Investigational Drugs, Volume 20, Issue 9 (2011)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Volume 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Discontinued Drug Perspective

Article

Discontinued drugs 2010: rheumatology, allergy and dermatology, pulmonary

Sabina A Antoniu MD PhD

Pages: 1175-1187

Published online: 28 Jul 2011

AbstractforDiscontinued drugs 2010: rheumatology, allergy and dermatology, pulmonary | Full Text | References | PDF (213 KB)

389 Views
0 CrossRef citations
0Altmetric

Original Research

Article

Crotamine toxicity and efficacy in mouse models of melanoma

Alexandre Pereira, Alexandre Kerkis, Mirian AF Hayashi, Aparecida SP Pereira, Fernando S Silva, Eduardo B Oliveira, Alvaro RB Prieto da Silva, Tetsuo Yamane, Gandhi Rádis-Baptista PhD & Irina Kerkis PhD

Pages: 1189-1200

Published online: 12 Aug 2011

AbstractforCrotamine toxicity and efficacy in mouse models of melanoma | Full Text | References | PDF (729.7 KB) | Supplemental

275 Views
50 CrossRef citations
0Altmetric

Reviews

Article

Migraine prophylactic drugs – something new under the sun?

Svein I Bekkelund & Karl B Alstadhaug

Pages: 1201-1210

Published online: 06 Aug 2011

AbstractforMigraine prophylactic drugs – something new under the sun? | Full Text | References | PDF (219.3 KB)

427 Views
6 CrossRef citations
0Altmetric

Article

Serotonin 2A receptor antagonists for treatment of schizophrenia

Bjørn H Ebdrup MD PhD, Hans Rasmussen PhD, Jørn Arnt PhD DSci & Birte Glenthøj MD DMSc

Pages: 1211-1223

Published online: 08 Jul 2011

AbstractforSerotonin 2A receptor antagonists for treatment of schizophrenia | Full Text | References | PDF (320.4 KB)

1191 Views
63 CrossRef citations
0Altmetric

Article

Development of c-MET pathway inhibitors

Xiangdong Liu, Robert C Newton & Peggy A Scherle

Pages: 1225-1241

Published online: 11 Jul 2011

AbstractforDevelopment of c-MET pathway inhibitors | Full Text | References | PDF (415.5 KB)

1042 Views
51 CrossRef citations
0Altmetric

Article

Pharmacologists and Alzheimer disease therapy: to boldly go where no scientist has gone before

Cesare Mancuso, Raffaella Siciliano, Eugenio Barone, David Allan Butterfield & Paolo Preziosi

Pages: 1243-1261

Published online: 02 Aug 2011

AbstractforPharmacologists and Alzheimer disease therapy: to boldly go where no scientist has gone before | Full Text | References | PDF (562.4 KB)

967 Views
36 CrossRef citations
0Altmetric

Article

Inhibiting signal transducer and activator of transcription 3: rationality and rationale design of inhibitors

Arun K Mankan & Florian R Greten

Pages: 1263-1275

Published online: 14 Jul 2011

AbstractforInhibiting signal transducer and activator of transcription 3: rationality and rationale design of inhibitors | Full Text | References | PDF (305.9 KB)

823 Views
67 CrossRef citations
0Altmetric

Article

Targeting voltage-gated calcium channels for the treatment of neuropathic pain: a review of drug development

Terry Pexton DO, Tobias Moeller-Bertram MD MAS, Jan M Schilling & Mark S Wallace MD

Pages: 1277-1284

Published online: 11 Jul 2011

AbstractforTargeting voltage-gated calcium channels for the treatment of neuropathic pain: a review of drug development | Full Text | References | PDF (203.8 KB)

1168 Views
44 CrossRef citations
0Altmetric

Article

New drugs for cystic fibrosis

Michael Wilschanski MBBS & Eitan Kerem MD

Pages: 1285-1292

Published online: 11 Jul 2011

AbstractforNew drugs for cystic fibrosis | Full Text | References | PDF (327.1 KB)

705 Views
6 CrossRef citations
0Altmetric

Drug Evaluation

Article

Targeting the insulin-like growth factor signaling pathway: figitumumab and other novel anticancer strategies

Timothy A Yap, David Olmos, Lulama Rhoda Molife & Johann S de Bono MB ChB FRCP MSc PhD

Pages: 1293-1304

Published online: 22 Jul 2011

AbstractforTargeting the insulin-like growth factor signaling pathway: figitumumab and other novel anticancer strategies | Full Text | References | PDF (469.9 KB)

383 Views
21 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Inflammation and Huntington’s disease- a neglected therapeutic target?

Sophie E. Field et al.

Review Article | Published online: 17 May 2024

Drugs in preclinical and early clinical development for the treatment of Chagas´s disease: the current status

Fernanda Karoline Vieira da Silva Torchelsen et al.

Review Article | Published online: 14 May 2024

Emerging therapies for overactive bladder: preclinical, phase I and phase II studies

Samantha Gibson et al.

Review Article | Published online: 9 May 2024

Frontotemporal dementia: from genetics to therapeutic approaches

Francesca R. Buccellato et al.

Review Article | Published online: 9 May 2024

Open Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.20, Iss.9, 2011)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?